Clinical Trial Update: Hydoxycarbamide and L-Carnitine Therapy in Sickle Cell Anemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating hydroxycarbamide and L-Carnitine therapy in sickle cell disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Hydroxycarbamide (hydroxycarbamide)
• L-carnitine (L-carnitine)

Snippet

Sponsor: Assiut University | Conditions: Sickle Cell Disease | Phase 4 | Status: COMPLETED